Hypertension and liver fibrosis may raise the risk of cancers outside the liver in people with metabolic ...

GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective ...

Hypertension in men and an increasing number of cardiometabolic criteria were associated with higher risk for advanced fibrosis and at-risk MASH.

A multianalyte blood test demonstrated superior sensitivity and noninferior specificity compared with ultrasound for hepatocellular carcinoma (HCC) detection in patients with cirrhosis, while ...

Investigators analyzed HCC incidence and incidence-based mortality trends by sex, race, and ethnicity, and stage at diagnosis to identify disparities between urban and rural patients.

Preview ASCO 2026 late-breaking cancer trials—from TNBC ADC survival gains to lung, liver, prostate and myeloma readouts ...

Dupilumab and upadacitinib were associated with greater improvements in AD severity when compared with methotrexate, cyclosporine, and phototherapy.

Junshi Biosciences receives approval of toripalimab NDA from NMPA for first-line treatment of HER2 expressing urothelial carcinoma: Shanghai Saturday, May 23, 2026, 17:00 Hrs [IST ...

Preeclampsia affects 1 in 25 pregnancies and is a leading cause of maternal death. Learn how low-dose aspirin may help reduce risks and improve outcomes for mothers and babies.

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

Response to febuxostat differed based on hyperuricemia subtype in older patients with gout, with the combined subtype linked to the lowest rates of SU target achievement.

POTOMAC trial subgroup analyses suggest favorable trends in delaying high-risk events and cystectomy with the addition of durvalumab to BCG I+M in patients with high-risk NMIBC, with manageable safety ...